IGF2BP2 Overexpression Indicates Poor Survival in Patients with Acute Myelocytic Leukemia

Conclusion: Thus, IGF2BP2 may serve as a biomarker to predict the prognosis of AML and as a potential target in AML.Cell Physiol Biochem 2018;51:1945 –1956
Source: Cellular Physiology and Biochemistry - Category: Cytology Source Type: research